SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer

2015142 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifier NCT00732914, www.clinicaltrials.gov.

Good health and well-being

Published in: European Urology

Volume 68, Issue 5, pp. 837-847

Field-Weighted Citation Impact: 18.80